Dishman Carbogen Amcis’ arm completes USFDA’s inspection at Switzerland manufacturing site

16 Feb 2023 Evaluate

Dishman Carbogen Amcis’ wholly owned subsidiary--Carbogen Amcis AG has successfully completed a routine U.S. Food and Drug Administration (USFDA) inspection at its manufacturing site in Bubendorf, Switzerland. The inspection was concluded without any major or critical observations.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

211.55 -7.40 (-3.38%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×